Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice

Experimental Cell Research

Volumn 254, Issue 2, 2000, Pages 241-248

  Truchet, Isabelle ^c   Jozan, Suzanne ^c   Guerrin, Marina ^a   Mazzolini, Laurent ^b   Vidal, Simone ^c   Valette, Annie ^c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c NONE

Author keywords

Apoptosis; Bcl 2; Estrogen withdrawal; MCF 7 cell xenografts; p21; Rb anti oncogene

Indexed keywords

CYCLIN D; ESTROGEN; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 0034142267     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4756     Document Type: Article

References (35)

1. Prall O. W. J., Sarcevic B., Musgrove E. A., Watts C. K. W., Sutherland R. L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272:1997;10882-10894.
2. Planas-Silva M. D., Weinberg R. A. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17:1997;4059-4069.
3. Lippman M. E., Dickson R. B. Mechanisms of normal and malignant breast epithelial growth regulation. J. Steroid Biochem. 34:1989;107-121.
4. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
5. Evan G. I., Brown L., Whyte M., Harrington E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:1995;825-834.
6. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
7. Qin X. Q., Livingston D. M., Kaelin W. G. Jr., Adams P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;10918-10922.
8. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
9. Hurd C., Khattree N., Dinda S., Alban P., Moudgil V. K. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene. 15:1997;991-995.
10. Watts C. K., Brady A., Sarcevic B., deFazio A., Musgrove E. A., Sutherland R. L. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol. 9:1995;1804-1813.
11. Shafie S. M., Grantham F. H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl. Cancer Inst. 67:1981;51-56.
12. Kyprianou N., English H. F., Davidson N. E., Isaacs J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51:1991;162-166.
13. Warri A. M., Huovinen R. L., Laine A. M., Martikainen P. M., Harkonen P. L. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natl. Cancer Inst. 85:1993;1412-1418.
14. Detre S., Salter J., Barnes D. M., Riddler S., Hills M., Johnston S. R., Gillett C., A'Hern R., Dowsett M. Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int. J. Cancer. 81:1999;309-313.
15. Pratt M. A., Krajewski S., Menard M., Krajewska M., Macleod H., Reed J. C. Estrogen withdrawal-induced human breast cancer tumor regression in nude mice is prevented by Bcl-2. FEBS Lett. 440:1998;403-408.
16. Osborne C. K., Coronado E. B., Robinson J. P. Human breast cancer in the athymic nude mouse: Cytostatic effects of long-term antiestrogen therapy. Eur. J. Cancer Clin. Oncol. 23:1987;1189-1196.
17. Tong W., Pollard J. W. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol. Cell Biol. 19:1999;2251-2264.
18. Morgenbesser S. D., Williams B. O., Jacks T., DePinho R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 371:1994;72-74.
19. Pan H., Griep A. E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes Dev. 8:1994;1285-1299.
20. Almasan A., Yin Y., Kelly R. E., Lee E. Y., Bradley A., Li W., Bertino J. R., Wahl G. M. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA. 92:1995;5436-5440.
21. Sandig V., Brand K., Herwig S., Lukas J., Bartek J., Strauss M. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med. 3:1997;313-319.
22. Fan G., Ma X., Kren B. T., Steer C. J. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene. 12:1996;1909-1919.
23. McConkey D. J., Goodrich D., Bucana C., Klostergaard J. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene. 13:1996;1693-1700.
24. Berry D. E., Lu Y., Schmidt B., Fallon P. G., C O. C., Hu S. X., Xu H. J., Blanck G. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene. 12:1996;1809-1819.
25. Haas-Kogan D. A., Kogan S. C., Levi D., Dazin P., A T. A., Fung Y. K., Israel M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
26. An B., Dou Q. P. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res. 56:1996;438-442.
27. Fattman C. L., An B., Dou Q. P. Characterization of interior cleavage of retinoblastoma protein in apoptosis. J. Cell. Biochem. 67:1997;399-408.
28. Janicke R. U., Walker P. A., Lin X. Y., Porter A. G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:1996;6969-6978.
29. Chen W. D., Otterson G. A., Lipkowitz S., Khleif S. N., Coxon A. B., Kaye F. J. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14:1997;1243-1248.
30. Tan X., Martin S. J., Green D. R., Wang J. Y. J. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272:1997;9613-9616.
31. Shan B., Chang C. Y., Jones D., Lee W. H. The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol. Cell. Biol. 14:1994;299-309.
32. Gill R. M., Hamel P. A., Zhe J., Zacksenhaus E., Gallie B. L., Phillips R. A. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ. 5:1994;467-474.
33. Mazel S., Burtrum D., Petrie H. T. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:1996;2219-2226.
34. Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 271:1996;12695-12698.
35. O'Reilly L. A., Huang D. C., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:1996;6979-6990.